WiCON | Pharma China (Web Edition)

The Market

Industry News

Regulatory News

General Health

	What Are the Lessons To Be Drawn from China's New Normal and the Latest Novel Co...
	Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on the lessons from the new normal of Chinese pharma and pos... (2/28/2020)

From China to the US: Best Business Practice Sharing amid the COVID-19 Pandemic (4/10/2020)

How to Use Chinese Policies Rolled Out amid COVID-19 (4/3/2020)

NMPA Finalizes Two Implementing Rules of the Drug Administration Law (4/2/2020)

Be Ready for the Dire Aftermath of the Post-Outbreak China Market (4/1/2020)

Bloomberg: Virus Likely Curtailed China Drug Output, Raising Shortage Fears (3/25/2020)

Amid Outbreak, French Economy’s Dependency on China in the Spotlight (3/25/2020)

Novel Coronavirus (COVID-19) Presents New Legal Challenges in China (3/24/2020)

CNBC: Peter Navarro Slams Big Pharma's Lobbying against Possible 'Buy America' Executive Order (3/20/2020)

EUCCC Reports Joint Survey Results on Impacts of COVID-19 on European business in China (3/15/2020)

Highlights of China's New Implementing Regulations for the Foreign Investment Law (3/12/2020)

Global Companies Expand the Reach of Their Cancer Drugs in China (3/11/2020)

The Coronavirus Long Battle: Trump Admin To Attack China’s Pharmaceutical Supply Chains (3/11/2020)

AmCham China Releases Extended COVID-19 Flash Survey Report (3/6/2020)

IQVIA Looks into The Epidemic Impact on China Healthcare Industry (3/6/2020)

What Are the Lessons To Be Drawn from China's New Normal and the Latest Novel Coronavirus Crisis? (2/28/2020)


	NH's DB6: Top Ten Chinese OTC Brands in ... (4/10/2020)
	CDE Solicits Public Comments for Clinica... (4/10/2020)
	Asia Pacific Drug Delivery Systems Marke... (4/10/2020)
	China Recruits Volunteers for Phase 2 Co... (4/9/2020)
	Asia Pacific and Chinese CRO Market Valu... (4/9/2020)
	Nicholas Hall's Review of China's OTC Dr... (4/9/2020)
	Boehringer Ingelheim Biopharmaceuticals ... (4/9/2020) (free)
	Infectious Diseases in Children and Adol... (4/9/2020)
	Regeneron and Zai Lab Announce Regional ... (4/8/2020)
	GenScript ProBio and Eutilex Partner to ... (4/8/2020)
	Immutep and EOC Continue to Advance Brea... (4/7/2020)
	CDE Solicits Public Comments for Clinica... (4/7/2020)
	CDE Solicits Public Comments for Clinica... (4/7/2020)
	GSK and Innovax in Partnership for COVID... (4/7/2020)
	Akeso Biotech Sets $300M IPO in Motion (4/7/2020)

	Pfizer to Absorb Mylan, Creating Global Generic Powerhou...
	PhRMA Calls for Trade Deals That Force Countries to Pay ...
	IQVIA: Global Pharma to Grow Slower in the Next Five Yea...
	Pfizer and GSK Announce JV to Create a Global Consumer H...
	Top 25 Global Pharmaceutical Companies by Market Cap 201...

	NH's DB6: Top Ten Chinese OTC Brands in 2019
	Asia Pacific Drug Delivery Systems Market Has Promising Opportu...
	Asia Pacific and Chinese CRO Market Value Projected to Expand B...
	Nicholas Hall's Review of China's OTC Drug Market Performance 2...
	Chinese Transmucosal Drug Delivery Systems Market to Rise 11% C...

	Boehringer Ingelheim Biopharmaceuticals China Receives “ISP...
	Regeneron and Zai Lab Announce Regional Strategic Collaborat...
	GenScript ProBio and Eutilex Partner to Develop Anti-cancer ...
	Immutep and EOC Continue to Advance Breast Cancer Drug Efti ...
	GSK and Innovax in Partnership for COVID-19 Vaccine R&am...

	CDE Solicits Public Comments for Clinical Research Guide...
	CDE Solicits Public Comments for Clinical Research Guide...
	CDE Solicits Public Comments for Clinical Research Guide...
	NMPA Issues Announcement on Contemporary Drug Distributi...
	NMPA Holds Teleconference for Major Drug Post-Marketing ...

	BrightGene Censured for False Claim on Gilead's Coronavirus ...
	USTR's 2019 Report for China's WTO Compliance Highlight IP a...
	Cardinal Health Settles with SEC for China-linked FCPA Alleg...
	Beijing High Rejects Novartis' Trademark Registration of "Al...
	Gilead's Antiviral Remdesivir Granted Three Patents in China...

	India Lifts Export Restrictions on 24 APIs
	China Claims Resumption of API Manufacture as Freight an...
	China Vows to Further Stabilize Production, Supply of Ac...
	China Begins Export of Many Pharma Ingredients to India
	U.S. Eyes Puerto Rico As Alternative to Chinese APIs

	China Recruits Volunteers for Phase 2 Coronavirus Vaccin...
	Ansun Bio Announces Positive Results from Trial of Novel...
	Henlius Novel Anti-EGFR mAb Shows Positive Results of It...
	Tsinghua: COVID-19 Vaccine and Antibodies Ready for Anim...
	BeyondSpring Initiates NDA Rolling Submission for Plinab...

	Infectious Diseases in Children and Adolescents in China...
	NHSA Releases Its 2019 Healthcare Security Sector Develo...
	China Issues Major Policy for Deepening Medical Insuranc...
	NHSA and MOHRSS Makes Name Changes to Certain Drugs List...
	NHSA and NHC Issues Policy for Internet+ Healthcare Serv...

	Recent Executive Moves
	Recent Executive Moves
	Recent Executive Moves
	Recent Executive Moves
	Recent Executive Moves

	Upcoming Event: 2nd World Congress on Dermatology and Ae...
	Upcoming Event: XI International Exhibition of Equipment...
	China Unveils New Measures to Keep Foreign Trade, Invest...
	AmCham China's Business Climate Survey 2020 - US compani...
	Upcoming Event: 6th Annual Biopharma Development and Pro...

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

WiCON Publishes the China Phar...

WiCON to Hold Pharma China Ann...

WiCON Publishes the China Phar...

WiCON Officially Publishes Chi...

Site map | Contact Us | Links